Prediction of Clinical Severity of COVID‐19 Using a Combination of Heparin‐Binding Protein, Interleukin‐6, and C‐Reactive Protein: A Retrospective Study
Male
Adult
heparin‐binding protein
Severity of Illness Index
SARS‐CoV‐2
Diseases of the respiratory system
03 medical and health sciences
COVID‐19
Predictive Value of Tests
Humans
Retrospective Studies
Aged
0303 health sciences
RC705-779
Interleukin-6
SARS-CoV-2
COVID-19
Blood Proteins
Middle Aged
Prognosis
C‐reactive protein
C-Reactive Protein
interleukin‐6
Original Article
Female
Carrier Proteins
prognostic marker
Biomarkers
Antimicrobial Cationic Peptides
DOI:
10.1111/crj.70003
Publication Date:
2024-08-27T02:59:51Z
AUTHORS (7)
ABSTRACT
ABSTRACT Background Systemic inflammation stands as a pivotal factor tightly interwoven with the progression of COVID‐19. This study endeavors to elucidate significance three key inflammatory molecules, that is, heparin‐binding protein (HBP), interleukin‐6 (IL‐6), and C‐reactive (CRP), in assessing severity prognostic implications Methods The demographic, clinical, laboratory data were retrospectively collected from cohort 214 adult patients diagnosed Patients divided into two groups: nonsevere ( n = 93; 43.5%) severe 121; 56.5%). Additionally, based on their organ function, categorized nonorgan failure 137) 77) groups. levels inflammation‐related cytokines then compared among these defined Results group was characterized by higher proportion males, older age, longer hospital stays cases. cases exhibited prevalence underlying diseases failure. Statistical analysis revealed significantly elevated HBP, IL‐6, CRP group. identified independent risk factors for Furthermore, combined assessment biomarkers demonstrated superior diagnostic sensitivity (85.10%) specificity (95.70%) predicting COVID‐19 severity. A positive relationship between impaired function also observed. predictive efficiency increased (hazard ratio 3.631, log‐rank p 0.003) when or more them combinedly used. Notably, associated an mortality. Conclusions In conclusion, offers enhanced accuracy severity, failure, mortality
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....